Dr. Martha Stewart, MD
Claim this profileClinical Trials Management, LLC
Studies Atopic Dermatitis
Studies Bullous Dermatitis
1 reported clinical trial
2 drugs studied
Affiliated Hospitals
More about Martha Stewart, MD
Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Martha Stewart, MD has experience with
- BMX-010
- Placebo
Breakdown of trials Martha Stewart, MD has run
Atopic Dermatitis
Bullous Dermatitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Martha Stewart, MD specialize in?
Martha Stewart, MD focuses on Atopic Dermatitis and Bullous Dermatitis. In particular, much of their work with Atopic Dermatitis has involved treating patients, or patients who are undergoing treatment.
Is Martha Stewart, MD currently recruiting for clinical trials?
No, Martha Stewart, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Martha Stewart, MD has studied deeply?
Yes, Martha Stewart, MD has studied treatments such as BMX-010, Placebo.
What is the best way to schedule an appointment with Martha Stewart, MD?
Apply for one of the trials that Martha Stewart, MD is conducting.
What is the office address of Martha Stewart, MD?
The office of Martha Stewart, MD is located at: Clinical Trials Management, LLC, Mandeville, Louisiana 70448 United States. This is the address for their practice at the Clinical Trials Management, LLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.